Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|January 1, 1996
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytesV G Brichard, J Herman, A Van Pel, et al.
The Journal of Experimental Medicine|August 1, 1993
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasV Brichard, A Van Pel, T Wölfel, et al.
International Journal of Cancer|October 31, 2000
Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitopeC Wölfel, I Drexler, A Van Pel, et al.
International Journal of Cancer|September 9, 1993
Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL)T Wölfel, M Hauer, E Klehmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3A Knuth, H Bernhard, E Jäger, et al.
Liver|December 30, 1998
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis BH F Löhr, S Krug, W Herr, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1M Sensi, C Traversari, M Radrizzani, et al.
The Clinical Investigator|December 1, 1994
Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infectionT Wölfel, P Schirmacher, J Schlaak, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutationE De Plaen, C Lurquin, A Van Pel, et al.
Gene Therapy|June 25, 2002
Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not manJ Kuball, M Schuler, E Antunes Ferreira, et al.
Pageof 4